News Agency
The Times Real Estate

Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China

  • Written by PR Newswire
Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China

-      ATG-037, an inhouse asset developed by Antengene and with global rights, has been approved to enter clinical studies in Australia and China, thus becoming the first oral small molecule CD73 inhibitor entering the clinical-stage in China and the wider Asia Pacific region. ATG-037 IND in Australia has been started...

Read more: Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73...

How to Send Money to the Pacific Islands: Step-by-Step Guide

Remitting money to the Pacific Islands can be very helpful to our families, friends and other business people there. Whether you are wiring money to Fiji, Samoa, Tonga, or any other island nation, it is crucial to get insight into... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion